• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床干预提高了普通外科质子泵抑制剂的合理使用。

Clinical Intervention Increases Rational Use of Proton Pump Inhibitors in the General Surgery Department.

作者信息

Chen Qiying, Wang Qiaohong, Zhang Yin

机构信息

Department of Pharmacy, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.

Department of Pharmacy, QuanZhou Women's and Children's Hospital, Quanzhou, China.

出版信息

Front Pharmacol. 2022 Apr 25;13:864081. doi: 10.3389/fphar.2022.864081. eCollection 2022.

DOI:10.3389/fphar.2022.864081
PMID:35548351
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9083545/
Abstract

This study aimed to evaluate the role of the clinical pharmacist in the rational use of proton pump inhibitors (PPIs) in a general surgery department. All enrolled patients had attended the general surgery department of a tertiary hospital. This single-center prospective study compared differences in the overall rate of rational PPI use, proportion of unindicated PPI use, utilization rate, average defined daily dose (DDD), drug costs, PPI costs, and cost-effectiveness of clinical pharmacist intervention between the intervention (538 cases) and control (536 cases) groups. In the intervention group, Pareto and fishbone diagram analyses were combined with the Plan-Do-Check-Act cycle; Statistical Package for the Social Sciences was used for analyzing all data. The overall rate of rational PPI use was significantly higher in the intervention group than in the control group ( < 0.01). The proportion of unindicated PPI use, utilization rate, average DDD, drug costs, and PPI costs were significantly lower in the intervention group than in the control group ( < 0.05). Cost-effectiveness analysis for the overall rate of rational PPI use indicated a positive impact of intervention, with economic benefits in the intervention group. Clinical pharmacist intervention for rational use of PPIs in general surgery departments could significantly increase the overall rate of rational PPI use; it could also reduce the proportion of unindicated PPI use, utilization rates, average DDDs, drug costs, and PPIs costs. Pharmacist intervention also offers economic benefits by improving the overall rate of rational PPI use.

摘要

本研究旨在评估临床药师在普通外科合理使用质子泵抑制剂(PPI)中的作用。所有纳入的患者均就诊于一家三级医院的普通外科。这项单中心前瞻性研究比较了干预组(538例)和对照组(536例)之间PPI合理使用的总体率、无指征使用PPI的比例、利用率、平均限定日剂量(DDD)、药品费用、PPI费用以及临床药师干预的成本效益的差异。在干预组中,将帕累托图和鱼骨图分析与计划-执行-检查-行动循环相结合;使用社会科学统计软件包分析所有数据。干预组PPI合理使用的总体率显著高于对照组(<0.01)。干预组无指征使用PPI的比例、利用率、平均DDD、药品费用和PPI费用均显著低于对照组(<0.05)。对PPI合理使用总体率的成本效益分析表明干预具有积极影响,干预组有经济效益。临床药师对普通外科合理使用PPI的干预可显著提高PPI合理使用的总体率;还可降低无指征使用PPI的比例、利用率、平均DDD、药品费用和PPI费用。药师干预通过提高PPI合理使用的总体率也带来了经济效益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/542e/9083545/004ec47cfe62/fphar-13-864081-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/542e/9083545/f3532079a591/fphar-13-864081-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/542e/9083545/030c98c78ad6/fphar-13-864081-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/542e/9083545/9a08dd3dcb58/fphar-13-864081-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/542e/9083545/7fffe139e2c5/fphar-13-864081-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/542e/9083545/004ec47cfe62/fphar-13-864081-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/542e/9083545/f3532079a591/fphar-13-864081-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/542e/9083545/030c98c78ad6/fphar-13-864081-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/542e/9083545/9a08dd3dcb58/fphar-13-864081-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/542e/9083545/7fffe139e2c5/fphar-13-864081-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/542e/9083545/004ec47cfe62/fphar-13-864081-g005.jpg

相似文献

1
Clinical Intervention Increases Rational Use of Proton Pump Inhibitors in the General Surgery Department.临床干预提高了普通外科质子泵抑制剂的合理使用。
Front Pharmacol. 2022 Apr 25;13:864081. doi: 10.3389/fphar.2022.864081. eCollection 2022.
2
Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.过去十年质子泵抑制剂处方趋势的变化及药师对三级医院处方实践的影响。
BMC Health Serv Res. 2018 Jul 11;18(1):537. doi: 10.1186/s12913-018-3358-5.
3
Prospective prescription review system correlated with more rational PPI medication use, better clinical outcomes and reduced PPI costs: experience from a retrospective cohort study.前瞻性处方审核系统与更合理的 PPI 药物使用、更好的临床结局和降低 PPI 成本相关:来自回顾性队列研究的经验。
BMC Health Serv Res. 2023 Sep 20;23(1):1014. doi: 10.1186/s12913-023-09931-5.
4
Impact of interventions targeting the inappropriate use of proton-pump inhibitors by clinical pharmacists in a hepatobiliary surgery department.临床药师干预肝胆外科质子泵抑制剂不合理应用的效果评价。
J Clin Pharm Ther. 2021 Feb;46(1):149-157. doi: 10.1111/jcpt.13273. Epub 2020 Oct 5.
5
The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital.药物干预对中国一家医院质子泵抑制剂合理使用的影响。
Patient Prefer Adherence. 2017 Dec 27;12:21-26. doi: 10.2147/PPA.S150388. eCollection 2018.
6
Continuous improvement on the rationality of prophylactic injectable PPIs usage by a clinical pharmacist-led guidance team at a Chinese tertiary teaching hospital.中国一家三级教学医院的临床药师主导的指导团队对预防性注射用质子泵抑制剂使用合理性的持续改进。
J Int Med Res. 2020 Oct;48(10):300060520954729. doi: 10.1177/0300060520954729.
7
The impact of pharmacist intervention on the intravenous-to-oral switch therapy of proton pump inhibitors in cardiovascular surgery.药剂师干预对心血管手术中质子泵抑制剂静脉给药转换为口服给药治疗的影响。
Expert Opin Drug Saf. 2023 Jul-Dec;22(7):611-619. doi: 10.1080/14740338.2023.2172162. Epub 2023 Feb 2.
8
The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium.各种旨在改善比利时质子泵抑制剂和他汀类药物合理处方的举措的潜在影响。
Expert Rev Pharmacoecon Outcomes Res. 2013 Feb;13(1):141-51. doi: 10.1586/erp.12.88.
9
Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.质子泵抑制剂治疗急性上消化道出血的临床疗效及成本效益的系统评价
Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. doi: 10.3310/hta11510.
10
Impact of proton pump inhibitor management committee's multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments.质子泵抑制剂管理委员会的多方面干预对门诊和急诊科酸抑制剂处方模式的影响。
BMC Health Serv Res. 2022 Mar 29;22(1):417. doi: 10.1186/s12913-022-07820-x.

引用本文的文献

1
A systematic review and meta-analysis on pharmacist-led interventions for the management of peptic ulcer disease.关于药师主导的消化性溃疡疾病管理干预措施的系统评价和荟萃分析。
PLoS One. 2025 Mar 25;20(3):e0320181. doi: 10.1371/journal.pone.0320181. eCollection 2025.
2
The role of pharmacists in mitigating medication errors in the perioperative setting: a systematic review.药剂师在围手术期减少用药错误中的作用:一项系统评价
Syst Rev. 2025 Jan 14;14(1):12. doi: 10.1186/s13643-024-02710-1.
3
Effect of pharmacist care on clinical outcomes and therapy optimization in perioperative settings: A systematic review.

本文引用的文献

1
Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.过去十年质子泵抑制剂处方趋势的变化及药师对三级医院处方实践的影响。
BMC Health Serv Res. 2018 Jul 11;18(1):537. doi: 10.1186/s12913-018-3358-5.
2
Evaluation of Preanalytical Quality Indicators by Six Sigma and Pareto`s Principle.运用六西格玛和帕累托原则评估分析前质量指标
Indian J Clin Biochem. 2018 Jan;33(1):102-107. doi: 10.1007/s12291-017-0654-5. Epub 2017 Apr 21.
3
The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital.
药剂师护理对围手术期临床结局及治疗优化的影响:一项系统评价
Am J Health Syst Pharm. 2024 Dec 16;82(1):44-73. doi: 10.1093/ajhp/zxae177.
4
Impact of pharmacist-evaluated clinical decision support system alerts on potentially missing or inappropriately prescribed proton pump inhibitors at hospital discharge: a retrospective cross-sectional study.药师评估的临床决策支持系统警报对出院时潜在漏用或不适当处方质子泵抑制剂的影响:一项回顾性横断面研究。
Int J Clin Pharm. 2024 Oct;46(5):1143-1151. doi: 10.1007/s11096-024-01746-6. Epub 2024 Jun 13.
5
Analysis of inappropriate prophylactic use of proton pump inhibitors during the perioperative period: an observational study.围手术期质子泵抑制剂不适当预防性使用的分析:一项观察性研究。
Perioper Med (Lond). 2024 Mar 14;13(1):19. doi: 10.1186/s13741-024-00376-w.
6
Application effect of PDCA circulation on nursing quality management and risk control in digestive endoscopy room.PDCA 循环在消化内镜室护理质量管理与风险控制中的应用效果。
Medicine (Baltimore). 2023 Dec 1;102(48):e35885. doi: 10.1097/MD.0000000000035885.
7
Prospective prescription review system correlated with more rational PPI medication use, better clinical outcomes and reduced PPI costs: experience from a retrospective cohort study.前瞻性处方审核系统与更合理的 PPI 药物使用、更好的临床结局和降低 PPI 成本相关:来自回顾性队列研究的经验。
BMC Health Serv Res. 2023 Sep 20;23(1):1014. doi: 10.1186/s12913-023-09931-5.
8
Impact of Pharmacist-Led PDCA Cycle in Reducing Prescription Abandonment: An Action Research from China.药师主导的PDCA循环对减少处方废弃的影响:一项来自中国的行动研究
Patient Prefer Adherence. 2023 Aug 29;17:2145-2152. doi: 10.2147/PPA.S418219. eCollection 2023.
药物干预对中国一家医院质子泵抑制剂合理使用的影响。
Patient Prefer Adherence. 2017 Dec 27;12:21-26. doi: 10.2147/PPA.S150388. eCollection 2018.
4
Implementation and progress of clinical pharmacy in the rational medication use in a large tertiary hospital.大型三级医院临床药学在合理用药中的实施与进展
Einstein (Sao Paulo). 2011 Dec;9(4):456-60. doi: 10.1590/S1679-45082011AO2140.
5
Is the era of intravenous proton pump inhibitors coming to an end in patients with bleeding peptic ulcers? Meta-analysis of the published literature.静脉注射质子泵抑制剂治疗消化性溃疡出血患者的时代即将结束?已发表文献的荟萃分析。
Br J Clin Pharmacol. 2016 Sep;82(3):880-9. doi: 10.1111/bcp.12866. Epub 2016 Jun 12.
6
Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review.对出院后因疏忽继续使用医院起始的质子泵抑制剂进行应激性溃疡预防而产生的费用评估:一项回顾性病历审查。
Ther Clin Risk Manag. 2015 May 24;11:649-57. doi: 10.2147/TCRM.S81759. eCollection 2015.
7
Intravenous proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: determining statistical equivalence according to evidence-based methods.
Int J Clin Pharmacol Ther. 2014 Oct;52(10):825-9. doi: 10.5414/CP202124.
8
Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial.静脉注射氟哌啶醇对危重症患者谵妄和昏迷持续时间的影响(Hope-ICU):一项随机、双盲、安慰剂对照试验。
Lancet Respir Med. 2013 Sep;1(7):515-23. doi: 10.1016/S2213-2600(13)70166-8. Epub 2013 Aug 21.
9
Four-year trends of inappropriate proton pump inhibitor use after hospital discharge.出院后质子泵抑制剂不恰当使用的四年趋势。
South Med J. 2013 Apr;106(4):270-3. doi: 10.1097/SMJ.0b013e31828db01f.
10
Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care.质子泵抑制剂在医院出院时的推荐及在初级保健中的持续使用的适宜性。
Int J Clin Pract. 2012 Aug;66(8):767-773. doi: 10.1111/j.1742-1241.2012.02973.x.